Scientists react to news that the FDA are delaying a decision on the Alzheimer’s drug Donanemab. Prof Robert Howard, … read more
A study published in Nature Aging looks at possible plasma protein biomarkers for dementia risk. Dr Sheona Scales, Director of Research … read more
A study published in Neurology looks at erectile dysfunction drugs and risk of Alzheimer’s Disease. Dr Francesco Tamagnini, Neurophysiologist at the … read more
A study published in Nature Medicine looks at Alzheimer’s Disease in recipients of cadaveric pituitary-derived growth hormone. Dr Richard Oakley, Associate … read more
A study published in JAMA Neurology looks at Tau immunoassays for Alzheimer’s Disease Dr Richard Oakley, Associate Director of Research and … read more
A study published in JAMA Otolaryngology–Head & Neck Surgery looks at hearing loss and hearing aid use and the risk of dementia. … read more
A study published in The Lancet Regional Health – Western Pacific looks at cholesterol levels and the risk of dementia. … read more
The way dementia is diagnosed has barely changed for nearly two decades, and here’s the shocker: at least a third … read more
A study published in Nature Medicine looks at neuroprosthesis to improve mobility of people living with Parkinson’s Disease. Prof David … read more
A study published in Lancet Public Health looks at the dementia incidence trend in England and Wales. Prof Marcus Richards, Professor … read more
A study published in the Journal of Neurology, Neurosurgery and Psychiatry looks at the effect of long term Tai Chi training … read more
A study published in Current Biology looks at navigational mistakes as a possible sign of Alzheimer’s disease. Dr Leah Mursaleen, Head … read more
An observational study published in JAMA Internal Medicine compares particulate air pollution from different emission sources and incident dementia in … read more
A conference abstract (not a published paper) presented at NUTRITION 2023 looks at olive oil intake and dementia risk. … read more
Results of trial looking at the use of hearing aids for cognitive decline has been published in The Lancet. … read more
Results from Eli Lilly’s TRAILBLAZER-ALZ 2 Randomized Clinical Trial looking at the use of donanemab in early symptomatic Alzheimer’s disease … read more
An observational study published in The BMJ looks at menopausal hormone therapy and dementia. Dr Anita McGrogan, Senior Lecturer … read more
A press release from Eli Lilly states that their antibody treatment, donanemab, significantly slowed cognitive and functional decline in phase … read more
Results of a phase 1b trial, looking at Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease, has been published in … read more
An observational study published in The Lancet Public Health looks at hearing aid use and all-cause and cause-specific dementia. … read more